ATA Guidelines Tools

Thyroid Disease in Preconception, Pregnancy, and Postpartum

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1545288

Contents of this Issue

Navigation

Page 24 of 53

25 Recommendations Table 13. Evaluation of Hyperthyroidism in Pregnancy Strength * Level # yroid function testing should not be pursued in pregnant women with hyperemesis gravidarum if there are no other clinical signs of hyperthyroidism a . Good Practice Statement yroid ultrasonography is not suggested as a method to distinguish GTT from Graves' disease in pregnant women. Conditional Low Isotope scanning is contraindicated in pregnancy and should not be used in the diagnostic evaluation of hyperthyroidism. Good Practice Statement a Predominantly palpitations that persist aer rehydration and antiemetics. If palpitations are caused by GTT, these can be treated symptomatically with propranolol. * Strength of Recommendation; # Level of Evidence; Good Practice Statement. Table 2. Distinguishing Between Gestational Transient Thyrotoxicosis (GTT) and Graves' Disease Feature GTT Graves' Disease Symptoms of thyrotoxicosis before pregnancy None Oen Symptoms of hyperemesis gravidarum (nausea/vomiting ) Oen Usually not present Personal or family history of thyroid disease Usually absent Oen present Presence of goiter None/low May be present as diffuse goiter Signs of thyroid eye disease None May be present Serum FT3 concentration (Box 6) Usually normal or mildly raised Raised Serum TRAb and/or TSI concentration Normal Raised Serum TT3 (ng/dL)/TT4 (mcg/dL) ratio Typically <20 Typically >20 Serum TSH concentration Usually normalizes by the third trimester of pregnancy Oen suppressed throughout pregnancy Hyperthyroidism

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Thyroid Disease in Preconception, Pregnancy, and Postpartum